SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-24-058808
Filing Date
2024-05-08
Accepted
2024-05-08 17:00:46
Documents
14
Period of Report
2024-02-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2413796d1_8ka.htm   iXBRL 8-K/A 80291
  Complete submission text file 0001104659-24-058808.txt   349458

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA abbv-20240214.xsd EX-101.SCH 4929
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abbv-20240214_def.xml EX-101.DEF 31173
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE abbv-20240214_lab.xml EX-101.LAB 41744
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abbv-20240214_pre.xml EX-101.PRE 29254
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2413796d1_8ka_htm.xml XML 14156
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35565 | Film No.: 24927280
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)